Themes for the 2nd Annual Australian Paediatric Immunotherapy Conference 2024 (APIC2024) include:

  • Tumour microenvironment and immunogenic therapies

  • Cell based immunotherapy

  • Tumour antigens and vaccines

PROGRAM

PROGRAM COMMENCEMENT@ The Larwill Studio, Melbourne

Opening Sessions: 8.45am - 10.30am

Welcome & Introduction

Keynote Lecture: Prof Crystal Mackall, Professor, Stanford University
Developing CAR T Cells for Pediatric Solid Cancers

Lecture: Dr Seong Lin Khaw
CD19 CAR T cell therapy for ALL- Lessons and Challenges in 2024

MORNING TEA @ The Larwill Studio 10.30am - 11am

Sessions: 11.00am - 12.20pm : TUMOUR MICROENVIRONMENT AND IMMUNOGENIC THERAPIES

Prof Di Yu, Ian Frazer Centre for Children's Immunotherapy Research, University of Queensland
Regulation of T cell homeostasis and function by ferroptosis

Chelsea Mayoh, CCIA, UNSW
Exploring the tumour immune microenvironment in paediatric cancer

Dr Charlotte S. Chen, Peter MacCallum Cancer Centre
In depth characterisation of the tumour immune microenvironment in paediatric solid tumours

Dr Klaartje Somers, CCIA, UNSW
Reprogramming the tumour microenvironment in solid paediatric cancers to enhance immunotherapy efficacy

Erin Coll, CCIA, UNSW
The chemotactic landscape of paediatric solid tumours

Associate Professor Raelene Endersby, Telethon Kids Institute, Perth
Investigating age-specific changes in the brain cancer immune microenvironment and how this modulates response to therapy

Rob Salomon, CCIA, UNSW
ASpIRe: a national resource for advancing paediatric immune-oncology research

LUNCH @ The Larwill Studio 12.20pm - 1.20pm

Sessions: 1.20pm - 3.30pm: CELL BASED IMMUNOTHERAPY

Dr Allie Lam, UQ Frazer Institute
Empowering Immunotherapy: Harnessing Adoptive NK Cells in the Fight Against Sarcoma

Prof Phil Darcy
Overexpression of FOXO1 in CAR T cells enhances stemness, metabolic fitness and anti-tumour efficacy

Assoc Prof Paul Beavis, Peter MacCallum Cancer Centre
Next generation CRISPR/HDR armoured CAR T cells

Prof Misty Jenkins, WEHI
Developing novel immunotherapies for brain cancer

Vicky Qin, Peter MacCallum Cancer Centre
Engineering a TGF-β switch receptor enhances CAR-T cell fitness and anti-tumor efficacy in immunosuppressive models

Dr Jessica Li, Peter MacCallum Cancer Centre
The Centre of Excellence in Cellular Immunotherapy at Peter Mac

Prof David Zeigler, Sydney Children’s Hospital
Australia’s first Paediatric Brain Cancer CAR T cell trial

AFTERNOON TEA @ The Larwill Studio 3.30pm - 4.00pm

Sessions: 3.00pm - 4.30pm: TUMOUR ANTIGENS AND VACCINES

Dr Pouya Faridi, Hudson Institute of Medical Research / Monash University
Inflammatory Microenvironment and Pediatric Solid Tumors: Implications for Antigenic Landscape and Immunotherapy Strategies

Dr Mohamed Fareh, Peter MacCallum Cancer Centre
RNA targeting with CRISPR-Cas13: From fundamental principles to therapeutic applications

OPEN DISCUSSION 4.30pm - 5.30pm

NETWORKING RECEPTION @ The Farmacy next to the Larwill Studio 5.30pm - 6.30pm

Monday 13 May 2024

* Please note this program is subject to change